Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
14. August 2018 07:48 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information
09. August 2017 16:39 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017
07. Februar 2017 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Reports On SequestOx™ FDA End-of-Review Meeting
23. Januar 2017 08:18 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported the Company received official minutes from its December 21, 2016...
Elite Provides Update on SequestOx™ New Drug Application
22. Dezember 2016 12:31 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced the Company met with the U.S. Food and Drug Administration (the...
Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015
05. November 2015 17:12 ET
|
Elite Pharmaceuticals, Inc.
Northvale, NJ, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of...
Elite Laboratories Files Citizen Petition With the FDA on Brompheniramine Maleate and Pseudoephedrine HCL Extended Release
10. Juni 2013 13:54 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 10, 2013 (GLOBE NEWSWIRE) -- Elite Laboratories, a wholly owned subsidiary of Elite Pharmaceuticals, Inc. (collectively ""Elite" or the "Company") (OTCBB:ELTP) today announced...